Don Jeffrey Diamond

This inventor holds 47 USPTO granted patents and 19 published patent applications, plus 3 CIPO patents and 2 EPO patents, primarily in Vaccine Development. Top assignees: Beckman Research Institute, City of Hope, Other. Active years: 2000-2026.

USPTO Granted Patents = 47 (Patent Applications = 19)

% Patents Active = 95.7

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 12)

Average Co-Inventor Count = 1.6

ph-index = 11

Forward Citations = 368(Granted Patents)

Company Filing History:

46 out of 692

Beckman Research Institute, City of Hope

patents

1 out of 834,411

Other

patents

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

CMV Vaccines

CAR T Cell Therapy

Tumor Immunotherapy

Modified Vaccinia Ankara

P53-targeting Vaccines

Endogenous Viral Vaccine

Immuno-reactive Peptides

Diagnostic Reagents

Synthetic Conjugates

CTL Epitopes

Vaccine Delivery

Cancer Vaccines

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12584146 - Synthetic modified vaccinia Ankara (SMVA) based coronavirus vaccines (2026-03-24),

2. 12527858 - MVA VECTORS FOR EXPRESSING MULTIPLE CYTOMEGALOVIRUS (CMV) ANTIGENS AND USE THEREOF (2026-01-20),

3. 12478672 - Use of Triplex CMV Vaccine in CAR T Cell Therapy (2025-11-25),

4. 12337032 - Genetically stable recombinant modified vaccinia Ankara (RMVA) vaccines and methods of preparation thereof (2025-06-24),

5. 12161714 - Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy (2024-12-10),

6. 12150987 - MVA vaccine for delivery of a UL128 complex and preventing CMV infection (2024-11-26),

7. 12054736 - Genetically modified recombinant vaccinia ankara (RMVA) vaccines of improved stability and methods of preparation thereof (2024-08-06),

8. 11844833 - Expression system for expressing herpesvirus glycoprotein complexes (2023-12-19),

9. 11717568 - MVA vaccine for delivery of a UL128 complex and preventing CMV infection (2023-08-08),

10. 11690908 - Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy (2023-07-04),

11. 11602554 - P53-targeting vaccines and pd-1 pathway inhibitors and methods of use thereof (2023-03-14),

12. 11541114 - Genetically stable recombinant modified vaccinia Ankara (rMVA) vaccines and methods of preparation thereof (2023-01-03),

13. 11389529 - Expression system for expressing herpesvirus glycoprotein complexes (2022-07-19),

14. 11384137 - MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof (2022-07-12),

15. 11141492 - Anticancer combinations (2021-10-12),

Title: The Innovative Journey of Don Jeffrey Diamond

Introduction: Don Jeffrey Diamond, a talented inventor hailing from Glendora, CA, has made significant contributions to the world of technology and innovation through his groundbreaking creations.

Latest Patents: Don Jeffrey Diamond's latest patents showcase his prowess in developing cutting-edge solutions in various industries, ranging from healthcare to renewable energy.

Career Highlights: With a career spanning over two decades, Don Jeffrey Diamond has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative products to fill them. His work has not only revolutionized existing technologies but has also paved the way for new advancements in the field.

Collaborations: Throughout his career, Don Jeffrey Diamond has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Don Jeffrey Diamond's passion for innovation and his dedication to pushing the boundaries of what is possible have solidified his position as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors to dream big and create the impossible.